Drug Type Small molecule drug |
Synonyms HSR 175 |
Target |
Action antagonists |
Mechanism ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H26ClFN2O5S |
InChIKeySXTWLAHDDMMBNF-BTQNPOSSSA-N |
CAS Registry125961-36-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypertension | Preclinical | Japan | - | |
Hypertension | Preclinical | - | - | |
Prostatic Hyperplasia | Preclinical | Japan | - | |
Prostatic Hyperplasia | Preclinical | - | - |